Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial

Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial

Objetive: Nonalcoholic fatty liver disease is an increasingly recognized condition that may progress to endstage liver disease. We investigated the effects of weight reduction and ursodeoxycholic acid administration in patients with this disease.Research methods and procedures: A double-blind, place...

Full description

Bibliographic Details
Main Authors: Nahum Méndez-Sánchez, Verónica González, Norberto Chávez-Tapia, Martha H Ramos, Misael Uribe
Format: Article
Language:English
Published: Elsevier 2004-07-01
Series:Annals of Hepatology
Subjects:
Nonalcoholic fatty liver disease
obesity
weight reduction
ursodeoxycholic acid
women
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119321039

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119321039

Similar Items